Simin Liang

462 total citations
33 papers, 323 citations indexed

About

Simin Liang is a scholar working on Molecular Biology, Cancer Research and Hematology. According to data from OpenAlex, Simin Liang has authored 33 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Cancer Research and 7 papers in Hematology. Recurrent topics in Simin Liang's work include Acute Myeloid Leukemia Research (6 papers), MicroRNA in disease regulation (4 papers) and Cancer-related molecular mechanisms research (3 papers). Simin Liang is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), MicroRNA in disease regulation (4 papers) and Cancer-related molecular mechanisms research (3 papers). Simin Liang collaborates with scholars based in China, France and Pakistan. Simin Liang's co-authors include Li Wang, Xin Gou, Wenxuan Wang, Xin Gou, Yunchun Kuang, Youlin Kuang, Haitao Yu, Jianxiang Chi, Xinyuan Li and Ying Jiang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Stroke and Nanoscale.

In The Last Decade

Simin Liang

30 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simin Liang China 11 154 83 65 48 40 33 323
Marni Stott‐Miller United States 14 162 1.1× 72 0.9× 110 1.7× 54 1.1× 56 1.4× 24 589
Habib Haybar Iran 9 96 0.6× 30 0.4× 34 0.5× 43 0.9× 27 0.7× 28 317
Jin Ju Kim South Korea 13 126 0.8× 48 0.6× 32 0.5× 78 1.6× 44 1.1× 42 400
Carolyn R. Lew United States 14 162 1.1× 101 1.2× 37 0.6× 24 0.5× 25 0.6× 29 471
Juan Zhou China 12 144 0.9× 84 1.0× 154 2.4× 122 2.5× 27 0.7× 19 383
Han Zhu China 12 175 1.1× 52 0.6× 29 0.4× 80 1.7× 40 1.0× 29 386
Yongyong Ma China 12 84 0.5× 33 0.4× 27 0.4× 136 2.8× 40 1.0× 33 316
Meagan Miller United States 5 106 0.7× 52 0.6× 104 1.6× 84 1.8× 29 0.7× 16 311
Amira Osman Egypt 14 132 0.9× 40 0.5× 46 0.7× 108 2.3× 15 0.4× 41 558

Countries citing papers authored by Simin Liang

Since Specialization
Citations

This map shows the geographic impact of Simin Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simin Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simin Liang more than expected).

Fields of papers citing papers by Simin Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simin Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simin Liang. The network helps show where Simin Liang may publish in the future.

Co-authorship network of co-authors of Simin Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Simin Liang. A scholar is included among the top collaborators of Simin Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simin Liang. Simin Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ou, Yangwen, Qiao Zuo, Weicai Chen, et al.. (2025). Stage-specific requirement for METTL3-dependent m6A epitranscriptomic regulation during myogenesis. Communications Biology. 8(1). 1317–1317.
2.
Si, Qin, Guangjie Zhang, Yu Fan, et al.. (2024). The role of imprinting genes’ loss of imprints in cancers and their clinical implications. Frontiers in Oncology. 14. 1365474–1365474. 3 indexed citations
3.
Zhou, Xiang, Li Mao, Haitao Yu, et al.. (2024). Roles of Akirin1 in early prediction and treatment of graft kidney ischemia‒reperfusion injury. SHILAP Revista de lepidopterología. 3(2). e20230043–e20230043. 4 indexed citations
4.
Liang, Simin, et al.. (2024). Design, synthesis and biological evaluation of artesunate-Se derivatives as anticancer agents by inducing GPX4-mediated ferroptosis. Bioorganic Chemistry. 152. 107733–107733. 8 indexed citations
6.
Wang, Qi, Simin Liang, Xian‐Li Ma, et al.. (2024). Design, docking optimization, and evaluation of biotin-PEG4-1,8-naphthalimide as a potent and safe antitumor agent with dual targeting of ferroptosis and DNA. RSC Medicinal Chemistry. 15(5). 1640–1651. 1 indexed citations
7.
Liang, Simin, Gui-Bin Liang, Huiling Wang, et al.. (2023). Discovery of 4-(N-dithiobenzyl piperazine)-1,8-naphthalimide as a potent multi-target antitumor agent with good efficacy, limited toxicity, and low resistance. European Journal of Medicinal Chemistry. 263. 115937–115937. 14 indexed citations
8.
Li, Xinyuan, Xiang Zhou, Li Mao, et al.. (2023). Small extracellular vesicles delivering lncRNA WAC-AS1 aggravate renal allograft ischemia‒reperfusion injury by inducing ferroptosis propagation. Cell Death and Differentiation. 30(9). 2167–2186. 33 indexed citations
9.
Zhou, Jianyu, Huiling Wang, Qi Wang, et al.. (2023). Design, synthesis, and antitumor evaluation of morpholine substituted bisnaphthalimides as DNA targeting agents. Bioorganic & Medicinal Chemistry Letters. 85. 129218–129218. 8 indexed citations
10.
Liang, Simin, et al.. (2023). Metabolomics Analysis and Diagnosis of Lung Cancer: Insights from Diverse Sample Types. International Journal of Medical Sciences. 21(2). 234–252. 8 indexed citations
12.
Li, Junnan, Pei Li, Simin Liang, et al.. (2023). Gene mutation analysis using next‐generation sequencing and its clinical significance in patients with myeloid neoplasm: A multi‐center study from China. Cancer Medicine. 12(8). 9332–9350. 5 indexed citations
13.
Xiao, Han, Jianghua He, Simin Liang, et al.. (2022). Racial/Ethnic Disparities on the Risk of Second Malignant Neoplasm Among Hodgkin Lymphoma Survivors. Frontiers in Oncology. 11. 790891–790891. 1 indexed citations
15.
Yin, Xiaoyan, et al.. (2020). <p>Risk Factors and a Nomogram for Predicting Intracranial Hemorrhage in Stroke Patients Undergoing Thrombolysis</p>. Neuropsychiatric Disease and Treatment. Volume 16. 1189–1197. 21 indexed citations
16.
Liang, Simin, et al.. (2020). HSPG2 overexpression independently predicts poor survival in patients with acute myeloid leukemia. Cell Death and Disease. 11(6). 492–492. 23 indexed citations
17.
Fan, Jing, Ying Jiang, Kaihui Hu, et al.. (2020). Barriers to using personal protective equipment by healthcare staff during the COVID-19 outbreak in China. Medicine. 99(48). e23310–e23310. 33 indexed citations
18.
Xiao, Han, Simin Liang, & Li Wang. (2020). Competing endogenous RNA regulation in hematologic malignancies. Clinica Chimica Acta. 509. 108–116. 11 indexed citations
19.
Liang, Simin, et al.. (2019). Prognostic value of DNMT3A mutations in myelodysplastic syndromes: a meta-analysis. Hematology. 24(1). 613–622. 10 indexed citations
20.
Liang, Simin, Wenxuan Wang, & Xin Gou. (2015). MicroRNA 26a modulates regulatory T cells expansion and attenuates renal ischemia–reperfusion injury. Molecular Immunology. 65(2). 321–327. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026